Avian Influenza: Information for Health Professionals and Laboratorians
In light of the recent case of human infection with highly pathogenic avian influenza A (H5N1) in North America, CDC is currently updating several of the H5N1 and general avian influenza interim guidance documents. The updated documents will be posted to this page as they are finalized. In the meantime, please refer to the most recent interim H7N9 and H5N1 documents available below.
Please note that until the updated documents are posted, and in instances when only H7N9 guidance is currently available, it is appropriate to use the H7N9 guidance for issues related to all human infection with avian influenza viruses that cause severe illness in people.
Testing and Reporting
- New! Testing Recommendations for Persons with possible infection with Highly Pathogenic Avian Influenza A (H5N1) virus in the United States
- New! Interim Guidance on Case Definitions for Investigations of Human Infection with Highly Pathogenic Avian Influenza A (H5N1) Virus in the United States January 13, 2014
Treatment and Prophylaxis
- Interim Guidance on the Use of Antiviral Agents for Treatment of Human Infections with Avian Influenza A (H7N9)
Chemoprophylaxis of Close Contacts
- CDC and USDA Interim Risk Assessment and Biosafety Level Recommendations for Working With Influenza A(H7N9) Viruses
- World Health Organization (WHO) Laboratory biorisk management for laboratories handling human specimens suspected or confirmed to contain avian influenza A(H7N9) virus causing human disease Interim recommendations [PDF, 74 KB]